Thomas K Equels bought $824 of AIM
CEO & President at AIM ImmunoTech Inc.. 107 shares at an average of $7.70, traded Jun 13, 2025, filed Jun 16, 2025.
Score components
- +25RoleCEO
- 0Trade size$824 at market
- -5Relative to holdingsUnder 1% of holdings (0.3%)
- +8Price context78% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying4 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -6.8%, 3m -73.2%, 6m -86.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-015207, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 13, 2025 | POpen-market purchase Common Stock | +107 | $7.70 | $824 | 38,885 | Jun 16, 2025 |
Related signals
Other insiders at AIM ImmunoTech Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 54Moderate | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $4,992 24,000 shares | +23% | |
| 51Moderate | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $2,310 11,000 shares | +12% | |
| 54Moderate | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $4,862 22,000 shares | +32% | |
| 46Moderate | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $1,292 5,900 shares | +9% | |
| 33Weak | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $896 103 shares | +0% | |
| 65Notable | AIM ImmunoTech Inc. | Ted D Kellner director | $50k 1,968,504 shares | first purchase | |
| 80Strong | AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $50k 1,968,504 shares | +104% | |
| 58Moderate | AIM ImmunoTech Inc. | William M Mitchell director | $5,000 196,851 shares | +61% | |
| 63Notable | AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $2,583 41,000 shares | +2% | |
| 48Moderate | AIM ImmunoTech Inc. | Peter W Rodino III COO, Secretary, Gen. Counsel | $44 500 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.